Microsatellite Instability-High (MSI-H)
Oncology·MeSH: Turcot syndrome
2 drugs in development·2 companies·1 clinical trial
Drug Pipeline by Phase
Phase 3(1)
| Drug | Company |
|---|---|
| tsr-042 | TESARO, Inc. (TSRO) |
Phase 1(1)
| Drug | Company |
|---|---|
| amg 436 | AMGEN INC (AMGN) |
Compare drugs
Frequently asked questions
How many drugs are in development for Microsatellite Instability-High (MSI-H)?
BioSniper tracks 2 drugs in development for Microsatellite Instability-High (MSI-H) across 2 companies.
How many clinical trials target Microsatellite Instability-High (MSI-H)?
There are 1 clinical trial targeting Microsatellite Instability-High (MSI-H) tracked by BioSniper.
Deep-dive into Microsatellite Instability-High (MSI-H)
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis